Identifying metabolic alterations in newly diagnosed small cell lung cancer patients
P Shona, JB Hansen, RG Maltesen, WM Szejniuk… - 2021 - qspace.qu.edu.qa
BackgroundSmall cell lung cancer (SCLC) is a malignant disease with poor prognosis. At
the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is …
the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is …
[HTML][HTML] Identifying metabolic alterations in newly diagnosed small cell lung cancer patients
S Pedersen, JB Hansen, RG Maltesen, WM Szejniuk… - Metabolism Open, 2021 - Elsevier
Background Small cell lung cancer (SCLC) is a malignant disease with poor prognosis. At
the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is …
the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is …
[PDF][PDF] Metabolism Open
S Pedersen, JB Hansen, RG Maltesen, WM Szejniuk… - researchgate.net
Background: Small cell lung cancer (SCLC) is a malignant disease with poor prognosis. At
the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is …
the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is …
P2. 12-14 A Pilot Study of Serial Plasma Metabolomics in Small Cell Lung Cancer Patients
S Lee, K Pathak, M Mcgilvrey, K Mansfield… - Journal of Thoracic …, 2019 - jto.org
Background Small cell lung cancer (SCLC) is among the deadliest cancers. SCLC is
characterized by high proliferation and high turn-over metabolism. There are few results of …
characterized by high proliferation and high turn-over metabolism. There are few results of …
Integrated omics and gene expression analysis identifies the loss of metabolite–Metabolite correlations in small cell lung cancer
Background and objective Small cell lung cancer (SCLC) is the most aggressive type of lung
carcinoma with high metastatic potential and chemoresistance upon relapse. Cancer cells …
carcinoma with high metastatic potential and chemoresistance upon relapse. Cancer cells …
Untargeted metabolomics and lipidomics identified four subtypes of small cell lung cancer
C Zhang, X Shang, H Wang - Metabolomics, 2022 - Springer
Introduction Small cell lung cancer (SCLC) is a heterogeneous malignancy with dismal
prognosis. However, few studies have conducted on the metabolic heterogeneity in SCLC …
prognosis. However, few studies have conducted on the metabolic heterogeneity in SCLC …
32P Untargeted metabolomics and lipidomics identified four subtypes of small cell lung cancer
C Zhang, X Shang, H Wang - Annals of Oncology, 2022 - annalsofoncology.org
Background Small cell lung cancer (SCLC) is a heterogeneous malignancy with dismal
prognosis. As molecular subtyping of SCLC with distinct genomic and transcriptional profiles …
prognosis. As molecular subtyping of SCLC with distinct genomic and transcriptional profiles …
Construction of a diagnostic model for small cell lung cancer combining metabolomics and integrated machine learning
X Shang, C Zhang, R Kong, C Zhao, H Wang - The Oncologist, 2024 - academic.oup.com
Background To date, no study has systematically explored the potential role of serum
metabolites and lipids in the diagnosis of small cell lung cancer (SCLC). Therefore, we …
metabolites and lipids in the diagnosis of small cell lung cancer (SCLC). Therefore, we …
1662P Comprehensive analysis of the metabolic enzymes in patients with small cell lung cancer using a large-scale targeted proteomics assay
G Toyokawa, M Kodama, N Haratake… - Annals of …, 2021 - annalsofoncology.org
Background Small cell lung cancer (SCLC) is a devastating subtype of lung cancer, and its
biological, clinical and genetic characteristics differ from those associated with non-small …
biological, clinical and genetic characteristics differ from those associated with non-small …
Comprehensive metabolic profiling and vulnerabilities to metabolic inhibitors among small cell lung cancer subtypes
KR Cargill, CM Gay, RJ Cardnell, YH Fan, Q Wang… - Cancer Research, 2020 - AACR
Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor that constitutes
approximately 14% of all lung cancers diagnosed in the United States. Despite recent …
approximately 14% of all lung cancers diagnosed in the United States. Despite recent …